Skip to main content
NCBI home page
Applied Microbiology logoLink to Applied Microbiology
. 1969 Nov;18(5):906–910. doi: 10.1128/am.18.5.906-910.1969

Activation of Coagulase Clotting by Trypsin Inhibitor

D S Orth 1,2, A W Anderson 1,2, M W Montgomery 1,2
PMCID: PMC378111  PMID: 4244303

Abstract

Egg white trypsin inhibitor activated coagulase clotting when added to a final concentration between 2 and 60 mg/ml. The greatest increase in clotting rate was observed in reaction mixtures containing the lowest concentrations of serum and plasma. Maximal activation was reached with 40 mg of trypsin inhibitor per ml when either serum or plasma was used as the source of coagulase-reacting factor (CRF). The increased rate of clotting is partly due to inhibition of plasmin. Freezing and thawing reduced plasma clotting inhibition. Soybean trypsin inhibitor also activated the coagulase reaction. The increased rate of clotting was observed with a coagulase preparation from organisms which produced plasminogen activators and with the culture supernatant fraction from organisms which did not activate plasminogen to plasmin. The tube test for coagulase could be made more sensitive for some strains of staphylococci by increasing the concentration of CRF (added as plasma or serum) by adding trypsin inhibitor, or both.

Full text

PDF
906

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOBEL H., BERMAN D. T., SIMON J. Purification of staphylococcal coagulase. J Bacteriol. 1960 Jun;79:807–815. doi: 10.1128/jb.79.6.807-815.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DRUMMOND M. C., TAGER M. Enzymatic activities associated with clotting of fibrinogen by staphylocoagulase and coagulase-reacting factor and their inhibition by disopropylfluophosphate. J Bacteriol. 1962 May;83:975–980. doi: 10.1128/jb.83.5.975-980.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DUTHIE E. S., LORENZ L. L. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol. 1952 Feb;6(1-2):95–107. doi: 10.1099/00221287-6-1-2-95. [DOI] [PubMed] [Google Scholar]
  4. HAUGHTON G., DUTHIE E. S. The activation of staphylococcal free coagulase by plasma constituents and the hydrolysis of Nalpha-toluene-p-sulphonyl-L-arginine methyl ester (TAME) by activated coagulase. Biochem J. 1959 Feb;71(2):348–355. doi: 10.1042/bj0710348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HUTCHISON J. G. Muller's phenomenon and its relationship to plasminogen activation and to blood constituents producing opacity in an agar gel. J Pathol Bacteriol. 1962 Oct;84:289–306. doi: 10.1002/path.1700840204. [DOI] [PubMed] [Google Scholar]
  6. McCANN S. F., LASKOWSKI M. Determination of trypsin inhibitor in blood plasma. J Biol Chem. 1953 Sep;204(1):147–152. [PubMed] [Google Scholar]
  7. SHERRY S., TROLL W. The action of thrombin on synthetic substrates. J Biol Chem. 1954 May;208(1):95–105. [PubMed] [Google Scholar]
  8. TAGER M. Problems in the coagulation of plasma by staphylocoagulase. Ann N Y Acad Sci. 1956 Aug 31;65(3):109–118. doi: 10.1111/j.1749-6632.1956.tb36629.x. [DOI] [PubMed] [Google Scholar]
  9. TAURASO N. M., WHITE D. A. Studies on staphylococcal infections. I. Interrelation of phage type and some physiological properties of staphylococci, with special reference to the Muller factor. Am J Dis Child. 1963 Feb;105:164–174. [PubMed] [Google Scholar]
  10. TURNER F. J., SCHWARTZ B. S. The use of a lyophilized human plasma standardized for blood coagulation factors in the coagulase and fibrinolytic tests. J Lab Clin Med. 1958 Dec;52(6):888–894. [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES